We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jennifer Richer

Jennifer Richer PhD

Associate Professor, Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Dr. Richer’s laboratory studies female sex steroid hormone receptor action in breast and gynecologic cancers. Recent research focus is on the role of the androgen receptor in the various subtypes of breast cancer, and the use of new generation anti-androgens as therapy. The lab also studies microRNAs (miRNAs) that influence tumor formation and progression in women’s cancers.

Education and Appointments: Dr. Richer received her Bachelor and Masters of Science Degrees from the University of Texas in 1986 and 1988 respectively. She then completed her doctorate in Pathology and Cell and Molecular Biology from Colorado State University in 1992. She thencompleted a fellowship with Dr. Kathryn Horwitz at the University of Colorado, Division of Endocrinology, where she identified genes differentially regulated by progesterone receptor isoforms in breast cancer. In 2007 Dr. Richer joined the faculty in the Department of Pathology, University of Colorado Anschutz Medical Campus, where she is an active mentor of graduate students and post-doctoral fellows and directs the Cancer Biology graduate course.

Endocrine Society Service: Dr. Richer has been a full member of the Endocrine Society since 1999 and served on the Annual Meeting Steering Committee from 2008-2011 and Scientific & Educational Programs Core Committee 2013-2016. She is also an active member of AACR and one of the co-organizers of the Keystone Symposia on Nuclear Hormone Receptors in 2016.